One Health News

Search News:
Found 599 Matching Results. View archived News Here.

ANNOUNCING the Twelfth “One Medicine Symposium” – December 9-10, 2015 - Durham, North Carolina (USA) - Monday, November 30, 2015

ANNOUNCING the Twelfth “One Medicine Symposium” – December 9-10, 2015 - Durham, North Carolina (USA)

Registration is now open for the Twelfth One Medicine Symposium entitled “Teaming Up Against the Flu: A One Medicine Approach to Influenza at the Human-Animal Interface.”

Dates: December 9-10, 2015

Location: Sheraton Imperial Hotel and Convention Center, Durham, NC

Registration Link:

Please visit the website for more information: 

The One Medicine Symposium is hosted by the NC Department of Agriculture and Consumer Services and NC Department of Health and Human Services in cooperation with NC State University College of Veterinary Medicine, UNC Gillings School of Global Public Health, USDA APHIS Veterinary Services, and NCSU Office of Professional Development. This annual conference provides professionals from a variety of backgrounds with current information and take-home tools to improve awareness and understanding of the topics from a One Medicine perspective, promote collaboration across professional disciplines, and enhance preparedness for natural or man-made disasters, infectious disease outbreaks, and other challenges affecting human and animal health.

NOTE:  Scheduled speaker Wednesday, December 9, 2015 at 10:00 a.m.

Greg Gray, MD, MPH, Professor, Division of Infectious Diseases, Global Health Institute, & Nicholas School of the Environment, Duke University

·         Overview of One Medicine/One Health concept

·      Overview of influenza from a multi-species and multi-disciplinary perspective

·      Q&A/Discussion

Dr. Gray is a member of the One Health Initiative team’s Honorary Advisory Board  

Anna Allen, DVM

Public Health Liaison Veterinarian

Emergency Programs Division

North Carolina Department of Agriculture & Consumer Services

919-807-4340 (office)

919-619-2023 (cell)

919-807-4303 (fax)

NOTICE: E-mail correspondence to and from this address may be subject to the North Carolina Public Records Law and may be disclosed to third parties by an authorized state official.


19th Annual Conference on Vaccine Research - April 18-20, 2016, Baltimore, MD (USA) - Monday, November 23, 2015

Important for One Health advancement...

19th Annual Conference on Vaccine Research


April 18-20, 2016, Baltimore, MD (USA)

Earn up to 19.0 Continuing Education Credits (CME)

Also see: and

The National Foundation for Infectious Diseases (NFID) welcomes abstract submittals for oral or poster presentation at the 2016 Annual Conference on Vaccine Research (ACVR), scheduled for April 18-20, 2016 in Baltimore, MD. The deadline for abstract submissions is 11:59 pm on December 1, 2015.

The 2 ½ day conference provides a forum for high-quality, current reports of scientific progress and best practices, and brings together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. Join international scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials at this exciting conference designed to encourage the exchange of ideas across a broad range of disciplines.

Additionally, NFID invites individuals in the early stages of their career in any field of vaccinology to apply for the Maurice R. Hilleman Early-Stage Career Investigator Award which includes $10,000 to support future research.

Ready to submit? Visit the online abstract submission site:

Provided by:

Ashley Cavell

Coordinator, Professional Education

National Foundation for Infectious Diseases

7201 Wisconsin Ave., Suite 750

Bethesda, MD 20814

T: 301.656.0003 x 16

F: 301.907.0878


USDA Embraces One Health Approach for Solving Problems Associated with Antimicrobial Resistance - Tuesday, November 17, 2015

USDA Embraces One Health Approach for Solving Problems Associated with Antimicrobial Resistance

Posted by Dr. Catherine Woteki, USDA Chief Scientist and Under Secretary for Research, Education and Economics, on November 16, 2015 at 4:00 PM

See more at:

This week is World Antibiotic Awareness Week and USDA remains focused on prolonging the usefulness of a very precious resource—antibiotics.  These medicines successfully treat and prevent infectious diseases and must be used responsibly to remain effective to all who need them.  USDA also recognizes that antimicrobial resistance, or the ability of bacteria and other microbes to survive the effects of an antibiotic and then proliferate, is a serious threat to both animal health and human health.

Earlier this year, the World Health Assembly developed a global action plan to combat antimicrobial resistance (AMR).  The five objectives of the plan are: Increasing awareness, strengthening research and surveillance, reducing infections, optimizing antimicrobial use, and ensuring sustainable investments to contain AMR.

At USDA, we use a One Health approach that embraces the idea that a problem such as AMR arising at the intersection of the health of humans, animals, and the environment can be solved only through a coordinated multidisciplinary approach.

Within USDA, there are eight agencies engaged in addressing some aspect of AMR: the Agricultural Research Service, the Agricultural Marketing Service, the Animal and Plant Health Inspection Service, the Economic Research Service, the Food Safety and Inspection Service, the Foreign Agricultural Service, the National Agricultural Statistics Service, and the National Institutes for Food and Agriculture. Our One Health Joint Working Group within USDA coordinates the work of these agencies for a comprehensive approach to address multiple facets of the issue.

Last year, USDA developed an AMR Action Plan based on broad stakeholder and federal partner feedback. The USDA AMR Action Plan outlines USDA’s current activities across USDA agencies and proposes a comprehensive, integrated approach for future activities that includes monitoring and surveillance; research and development; and education and outreach. Data collection through monitoring and surveillance provides the fuel for targeting research into epidemiology, ecology, and preventive health approaches allowing for development of critical mitigation strategies. Education and outreach are necessary to spread the word and enhance implementation of findings.

USDA’s AMR Action Plan provides the details of USDA’s responsibilities outlined in the Combating Antibiotic Resistant Bacteria (CARB) National Action Plan, developed with our federal partners. In both of these plans, we take advantage of the strengths of our existing activities and collective experience in animal agriculture and describe additional work necessary to fill knowledge gaps. 

Our understanding of the factors that contribute to development of infectious disease, which includes those that are resistant to antibiotics in various settings, is incomplete. Agricultural systems are diverse and complex even within a specific commodity group. To identify and apply effective mitigation strategies, it is critical for many disciplines to work together to improve our understanding of where pathogens originate, how they interact in the environment, and how we can effectively diminish their occurrence. A “One-Health” approach is needed to prevent, not just react to, complex public and animal health issues. We also recognize that for prevention to be effective, we need to invest resources in a variety of strategies.  Risk management requires collaboration among human, animal, and environmental sectors.

The theme of the World Antibiotic Awareness Week campaign this year is, Antibiotics: Handle with Care. You can find what some of our stakeholders are doing to preserve this valuable resource through a Fact Sheet distributed during the White House Forum on Antibiotic Stewardship held June 2, 2015.

33 Prominent U.S. and international individual and organizational One Health Endorsements (multidisciplinary) – June 2011 to October 2015 - Saturday, November 14, 2015

33 Prominent U.S. and international individual and organizational One Health Endorsements (multidisciplinary) – June 2011 to October 2015

Posted One Health Initiative website – NEWS page (scroll back)

See Complete list:

Keynote Presentation One Health Challenges For The 21st Century [Cancer etc.] - Tuesday, November 10, 2015

A “must see” comprehensive One Health audio/video viewpoint [1 hour] for physicians, veterinarians, health scientists and researchers, political leaders, media and laypersons worldwide...especially human cancer patients (past, present and future)!

Keynote Presentation One Health Challenges For The 21st Century [Cancer etc.]

Published on Jun 22, 2015

“On April 7-8, 2015, the Office of Research Infrastructure Programs (ORIP) in the Division of Program Coordination, Planning, and Strategic Initiatives, sponsored a workshop on the National Institutes of Health (NIH) campus entitled, One Health: Integrating the Veterinarian Scientist into the Biomedical Research Enterprise.

One Health is defined as the integrative effort of multiple disciplines working together to attain optimal health for people, animals and the environment. The purpose of the workshop was to identify how the concept of One Health can advance the NIH mission in regard to both basic and applied research, including training of the biomedical work force, concentrating on the veterinarian scientist.” 

[Encompasses the internationally acknowledged “One Health Umbrella” concept]

Communicated by:

*Carolyn J. Henry, DVM, MS, DACVIM

Interim Associate Director of Research; Ellis Fischel Cancer Center, Facilitator, One Health/One Medicine;
Office of the Provost, Professor of Oncology; Veterinary Medical Teaching Hospital, University of Missouri (USA)
Professor of Oncology [cancer]
Department of Veterinary Medicine and Surgery, College of Veterinary Medicine and Division of Hematology/Oncology, School of Medicine
Director, Tom and Betty Scott Endowed Program in Veterinary Oncology

*Dr. Henry, a veterinarian, is a longstanding One Health Supporter/advocate and serves on the U.S. One Health Commission (OHC) Council of Advisors

Livestock Models in Translational Science - Institute for Laboratory Animal Research (ILAR) Journal Volume 65 Issue 1 2015 - Friday, November 06, 2015

Livestock Models in Translational Science


 “This issue of the Institute for Laboratory Animal Research (ILAR) Journal focuses on livestock models in translational medicine [One Health approach]. Livestock models of selected human diseases present important advantages as compared with rodent models for translating fundamental breakthroughs in biology to useful preventatives and therapeutics for humans. Livestock reflect the complexity of applying medical advances in an outbred species. … Conducting translational research using livestock models requires special facilities and researchers with expertise in livestock. There are many institutions in the world with experienced researchers and facilities designed for livestock research; primarily associated with colleges of agriculture and veterinary medicine or government laboratories.”


ILAR Journal, Volume 56 Issue 1 2015 -

Issue Editors: James A. Roth, DVM, PhD and Christopher K. Tuggle, PhD


To read the first article of this issue click


 Note:  Translational medicine is considered an important part of the One Health concept as shown under the internationally acknowledged “One Health Umbrella” graphic

One Health approach implementation supported...Hudson Institute Report: NATIONAL BLUEPRINT FOR BIODEFENSE, Released October 28, 2015 - Thursday, October 29, 2015

One Health approach implementation supported...

Hudson Institute Report




Released October 28, 2015

Report in full: 


Integrate animal health and One Health approaches into biodefense strategies.

Recommendation 7

a Institutionalize One Health.

b Develop a nationally notifiable animal disease system.

c Prioritize emerging and reemerging infectious diseases.



See pages 19 & 20

“...A One Health approach can also inform priorities for human infectious diseases. When it became clear in 2014 that no countermeasures for Ebola were ready for the largest Ebola outbreak the world had ever seen, many policy conversations that followed were about priorities. We must have a means of determining what to fund with finite resources. The threats and risks among agents of both bioterror and emerging infectious diseases are equally serious. MTDs have been very important for the prioritization of activities around biodefense, yet there is no analogous prioritization system for emerging diseases....”

“Recommendation 7 –[See page 21]

Integrate animal health and One Health approaches into biodefense strategies. Effective solutions for defense against emerging infectious disease and bioterror

threats lie at the interface of human, animal, and environmental health.


a. Institutionalize One Health. The White House should lead all relevant agencies to a new level of understanding, planning, and operating with respect to biodefense that includes an animal health and, more broadly, a One Health mindset. The Vice President

should direct the NSC to review all strategic biodefense documents to ensure that animal health and environmental health agencies are identified and assigned responsibility, and that their activities are fully aligned and coordinated with other biodefense activities and are current with respect to new science and evidence.

b. Develop a nationally notifiable animal disease system. The Administrator of the USDA Animal and Plant Health Inspection Service (APHIS), working with the Director of the Department of the Interior (DOI) U.S. Fish and Wildlife Service and other partners as appropriate, should develop a nationally notifiable animal disease list and implement a reporting system for states, localities, territories, tribes, and other owners of disease information. USDA should afford DHS, HHS, and other agencies engaged in biodefense access to the data in this system.

c. Prioritize emerging and reemerging infectious diseases. The Secretary of Health and Human Services, in coordination with the Secretary of Agriculture and Secretary of Defense, should prioritize emerging infectious disease threats. They should consider using a multi-criteria decision analysis tool and transparent methodology to develop these determinations. They should address pathogens and

pathogen families with the potential to cause a catastrophic public health emergency sufficient to affect national security, including agents known to infect wildlife and domestic animals. The list should drive funding in surveillance, response planning, MCM development, and any activities revealed as gaps per action item 3e.


A Critically Relevant One Health/PUBLIC HEALTH approach---New vaccines needed for pathogens infecting animals and humans: One Health - Dr. Thomas P. Monath - Monday, October 26, 2015

A Critically Relevant One Health/PUBLIC HEALTH approach – revisited…      

New vaccines needed for pathogens infecting animals and humans: One Health - Dr. Thomas P. Monath

Note: Thomas P. Monath, MD;, an eminent physician virologist/vaccine developer, is also a co-founder of the One Health Initiative Autonomous pro bono team (OHI) and the One Health Initiative website.


Published on May 1, 2013

World Vaccine Congress & Expo 2013

Dr Thomas P. Monath, Adjunct Professor at Harvard School of Public Health gives his presentation on 'New vaccines needed for pathogens infecting animals and humans: One Health'.

The World Vaccine Congress & Expo is now in its 13th year and is the biggest and most comprehensive event for the industry. Covering everything from the latest R&D to manufacturing to the corporate development strategies you'll be sure to find answers to all your questions.”

SEE: [This is instructive and sets the stage for understanding]

Following this talk, in October 2013 the OHI posted more details about this issue:

Vaccines against diseases transmitted from animals to humans: A one health paradigm

“This review focuses on the immunization of animals as a means of preventing human diseases (zoonoses). …”

In simple terms, the idea is to develop vaccines that protect domestic animals and wildlife thereby establishing effective barriers against human infections.  Developing animal vaccines are less expensive and are less strictly regulated than are those for humans.  Hopefully a common sense One Health approach can go forward.,%20MD%20Sept%202013%20One%20Health%20Vaccine%20Article.pdf  

Originally Posted One Health Initiative NEWS page October 9, 2013 - 

*Vaccines against diseases transmitted from animals to humans: A one health paradigm


Subsequently a supportive scientific publication December 31, 2014 was Posted:


Plant-based solutions for veterinary immunotherapeutics and prophylactics: Veterinary Research 2014, 45:117  doi:10.1186/s13567-014-0117-4

 “…So, it is viewed as inevitable by the One Health Initiative that humans need to reduce the use of antibiotics and turn to alternative, improved means to control disease: vaccination and prophylactics. …”


“An alarming increase in emergence of antibiotic resistance among pathogens worldwide has become a serious threat to our ability to treat infectious diseases according to the World Health Organization. Extensive use of antibiotics by livestock producers promotes the spread of new resistant strains, some of zoonotic concern, which increases food-borne illness in humans and causes significant economic burden on healthcare systems. Furthermore, consumer preferences for meat/poultry/fish produced without the use of antibiotics shape today’s market demand. So, it is viewed as inevitable by the One Health Initiative that humans need to reduce the use of antibiotics and turn to alternative, improved means to control disease: vaccination and prophylactics.  Besides the intense research focused on novel therapeutic molecules, both these strategies rely heavily on the availability of cost-effective, efficient and scalable production platforms which will allow large-volume manufacturing for vaccines, antibodies and other biopharmaceuticals. Within this context, plant-based platforms for production of recombinant therapeutic proteins offer significant advantages over conventional expression systems, including lack of animal pathogens, low production costs, fast turnaround and response times and rapid, nearly-unlimited scalability. Also, because dried leaves and seeds can be stored at room temperature for lengthy periods without loss of recombinant proteins, plant expression systems have the potential to offer lucrative benefits from the development of edible vaccines and prophylactics, as these would not require cold storage and transportation, and could be administered in mass volumes with minimal processing. Several biotechnology companies currently have developed and adopted plant-based platforms for commercial production of recombinant protein therapeutics. In this manuscript, we outline the challenges in the process of livestock immunization as well as the current plant biotechnology developments aimed to address these challenges.” 

MediLabSecure Endorses One Health - Friday, October 23, 2015

MediLabSecure Endorses One Health

Please see


...The MediLabSecure project aims at consolidating a Laboratory Network on the emerging viruses that are pathogens for humans and/or animals. It will represent a cluster for awareness, risk assessment, monitoring and control of these vector borne diseases. This cluster will require the interaction of four laboratory sub-networks, one for human health, one for animal health, one for entomology and one for public health reinforcement. ... full description in

MediLabSecure is a product of The Institut Pasteur which “was opened on November 14, 1888 thanks to Louis Pasteur’s international appeal for funds. He now had the facilities to extend vaccination against rabies, continue research on infectious diseases and share the resulting knowledge.” See more at: and


Bella Moss Foundation’s – Antibiotic Resistance “Speakers from the One Health Conference 13th October 2014 Royal Society of Medicine” - Tuesday, October 20, 2015

A timely One Health issue today (2015) as it was in 2014...

Bella Moss Foundation’s – Antibiotic Resistance “Speakers from the One Health Conference 13th October 2014 Royal Society of Medicine”

Beginning with prominent Public Health/One Health physician, David L. Heymann, MD – Editor, Control of Communicable Diseases Manual and Director, U.K. Health Protection Agency (United Kingdom). 

Please see and listen to:

Dr. Heymann is also a member of the One Health Initiative team’s Honorary Advisory Board

Please read Bella Moss Foundation’s webinar link fighting the battle of multidrug resistant infections and

Note: The American Association of Public Health Physicians (AAPHP) supports and advocates the One Health approach.

One Health Initiative
Home | About One Health | Mission Statement | One Health News | AVMA Task Force Report | One Health Newsletter |
Publications | Supporters | Supporter Endorsements | Upcoming Events | Contact Us